Literature DB >> 10961787

Clinical correlates of brain morphometric features of subjects with low-functioning autistic disorder.

M Elia1, R Ferri, S A Musumeci, S Panerai, M Bottitta, C Scuderi.   

Abstract

Numerous neuropathologic and imaging studies have reported different structural abnormalities in the brains of autistic subjects. However, whether or not the degree of brain abnormality is correlated with the severity of developmental impairment in autistic disorder is still unknown. The midsagittal area of the cerebrum, corpus callosum, midbrain, cerebellar vermis, and vermal lobules VI and VII was measured by means of magnetic resonance imaging in 22 boys with low-functioning autistic disorder and in 11 age-matched normal controls. Morphometric measures were statistically compared between groups and correlated with age and scores on the Psychoeducational Profile-Revised and the Childhood Autism Rating Scale. A significant negative correlation was found between midsagittal area of the cerebrum and age in patients with autistic disorder, and a positive correlation was found between the midsagittal area of the midbrain and some subscales of the Psychoeducational Profile-Revised.

Entities:  

Mesh:

Year:  2000        PMID: 10961787     DOI: 10.1177/088307380001500802

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  19 in total

1.  Brain growth across the life span in autism: age-specific changes in anatomical pathology.

Authors:  Eric Courchesne; Kathleen Campbell; Stephanie Solso
Journal:  Brain Res       Date:  2010-10-01       Impact factor: 3.252

2.  Corpus callosum morphometrics in young children with autism spectrum disorder.

Authors:  Inbal Boger-Megiddo; Dennis W W Shaw; Seth D Friedman; Bobbi F Sparks; Alan A Artru; Jay N Giedd; Geraldine Dawson; Stephen R Dager
Journal:  J Autism Dev Disord       Date:  2006-08

3.  Corpus callosum area and brain volume in autism spectrum disorder: quantitative analysis of structural MRI from the ABIDE database.

Authors:  R Kucharsky Hiess; R Alter; S Sojoudi; B A Ardekani; R Kuzniecky; H R Pardoe
Journal:  J Autism Dev Disord       Date:  2015-10

Review 4.  Structural and functional magnetic resonance imaging of autism spectrum disorders.

Authors:  Kimberly A Stigler; Brenna C McDonald; Amit Anand; Andrew J Saykin; Christopher J McDougle
Journal:  Brain Res       Date:  2010-12-03       Impact factor: 3.252

5.  Accurate automated detection of autism related corpus callosum abnormalities.

Authors:  Ayman El-Baz; Ahmed Elnakib; Manuel F Casanova; Georgy Gimel'farb; Andrew E Switala; Desha Jordan; Sabrina Rainey
Journal:  J Med Syst       Date:  2010-05-06       Impact factor: 4.460

6.  Brainstem volumetric alterations in children with autism.

Authors:  R J Jou; N J Minshew; N M Melhem; M S Keshavan; A Y Hardan
Journal:  Psychol Med       Date:  2008-09-24       Impact factor: 7.723

7.  Further empirical data on the psychoeducational profile-revised (PEP-R): reliability and validation with the Vineland adaptive behavior scales.

Authors:  Susanna Villa; Enrico Micheli; Laura Villa; Valentina Pastore; Alessandro Crippa; Massimo Molteni
Journal:  J Autism Dev Disord       Date:  2010-03

8.  Corpus callosum volume in children with autism.

Authors:  Antonio Y Hardan; Melissa Pabalan; Nidhi Gupta; Rahul Bansal; Nadine M Melhem; Serguei Fedorov; Matcheri S Keshavan; Nancy J Minshew
Journal:  Psychiatry Res       Date:  2009-09-24       Impact factor: 3.222

9.  A two-year longitudinal pilot MRI study of the brainstem in autism.

Authors:  Roger J Jou; Thomas W Frazier; Matcheri S Keshavan; Nancy J Minshew; Antonio Y Hardan
Journal:  Behav Brain Res       Date:  2013-04-22       Impact factor: 3.332

10.  Dorsolateral prefrontal cortex magnetic resonance imaging measurements and cognitive performance in autism.

Authors:  Jessica Griebling; Nancy J Minshew; Kimberly Bodner; Robin Libove; Rahul Bansal; Prasad Konasale; Matcheri S Keshavan; Antonio Hardan
Journal:  J Child Neurol       Date:  2010-01-21       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.